Zhong B, Zhang R, Luo S, Zheng J
Front Med (Lausanne). 2024; 11:1446936.
PMID: 39624040
PMC: 11609931.
DOI: 10.3389/fmed.2024.1446936.
Fontes E Sousa M, Campainha S, Marques I, Dinis R, Inacio J, Mendes J
Clin Drug Investig. 2024; 44(11):801-810.
PMID: 39500817
PMC: 11564330.
DOI: 10.1007/s40261-024-01400-z.
Cottin V, Martinez F, Smith V, Walsh S
Eur Respir Rev. 2024; 31(165).
PMID: 38743511
PMC: 9724802.
DOI: 10.1183/16000617.0003-2022.
Sanduzzi Zamparelli S, Sanduzzi Zamparelli A, Bocchino M
Diagnostics (Basel). 2023; 13(14).
PMID: 37510180
PMC: 10378270.
DOI: 10.3390/diagnostics13142437.
Margallo Iribarnegaray J, Churruca Arrospide M, Matesanz Lopez C, Perez Rojo R
Open Respir Arch. 2023; 5(2):100248.
PMID: 37496878
PMC: 10369608.
DOI: 10.1016/j.opresp.2023.100248.
Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease.
Berger K, Kaner R
Life (Basel). 2023; 13(3).
PMID: 36983755
PMC: 10055741.
DOI: 10.3390/life13030599.
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease.
Maher T, Schiffman C, Kreuter M, Moor C, Nathan S, Axmann J
Respir Res. 2022; 23(1):307.
PMID: 36369156
PMC: 9651119.
DOI: 10.1186/s12931-022-02221-4.
Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
Piotrowski W, Martusewicz-Boros M, Bialas A, Barczyk A, Batko B, Blasinska K
Adv Respir Med. 2022; 90(5):425-450.
PMID: 36285980
PMC: 9717335.
DOI: 10.3390/arm90050052.
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a Analysis.
Molina-Molina M, Kreuter M, Cottin V, Corte T, Gilberg F, Kirchgaessler K
Front Med (Lausanne). 2022; 9:897102.
PMID: 35783648
PMC: 9247211.
DOI: 10.3389/fmed.2022.897102.
Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.
Nili M, Singer D, Hanna M
BMC Pulm Med. 2022; 22(1):153.
PMID: 35459138
PMC: 9034591.
DOI: 10.1186/s12890-022-01953-9.
Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.
Todd N, Atamas S, Hines S, Luzina I, Shah N, Britt E
Expert Rev Respir Med. 2022; 16(2):235-245.
PMID: 35034567
PMC: 8983480.
DOI: 10.1080/17476348.2022.2030710.
The Application of Transbronchial Lung Cryobiopsy and Uniportal and Tubeless Video-Assisted Thoracic Surgery in the Multidisciplinary Diagnosis of Interstitial Lung disease-A Real-World Prospective Study.
Han Q, Chen X, Xu X, Qian W, Zhao G, Mao M
Front Mol Biosci. 2021; 8:681669.
PMID: 34222336
PMC: 8241905.
DOI: 10.3389/fmolb.2021.681669.
A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
Dodia N, Amariei D, Kenaa B, Corwin D, Chelala L, Britt E
Respir Med. 2021; 179:106333.
PMID: 33676119
PMC: 7992253.
DOI: 10.1016/j.rmed.2021.106333.
The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
Ageely G, Souza C, De Boer K, Zahra S, Gomes M, Voduc N
Can Respir J. 2020; 2020:9026171.
PMID: 32879642
PMC: 7448233.
DOI: 10.1155/2020/9026171.
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg).
Krauss E, El-Guelai M, Pons-Kuehnemann J, Dartsch R, Tello S, Korfei M
J Clin Med. 2020; 9(8).
PMID: 32756496
PMC: 7464480.
DOI: 10.3390/jcm9082499.
Multidisciplinary management of interstitial lung diseases: A real-life study.
Biglia C, Ghaye B, Reychler G, Koenig S, Yildiz H, Lacroix V
Sarcoidosis Vasc Diffuse Lung Dis. 2020; 36(2):108-115.
PMID: 32476943
PMC: 7247099.
DOI: 10.36141/svdld.v36i2.8107.
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?.
Sambataro D, Sambataro G, Pignataro F, Zanframundo G, Codullo V, Fagone E
Diagnostics (Basel). 2020; 10(4).
PMID: 32283744
PMC: 7235942.
DOI: 10.3390/diagnostics10040208.
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study.
Tirelli C, Morandi V, Valentini A, La Carrubba C, Dore R, Zanframundo G
Front Med (Lausanne). 2020; 7:11.
PMID: 32133362
PMC: 7040230.
DOI: 10.3389/fmed.2020.00011.
The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.
Furini F, Carnevale A, Casoni G, Guerrini G, Cavagna L, Govoni M
Front Med (Lausanne). 2019; 6:246.
PMID: 31750308
PMC: 6842981.
DOI: 10.3389/fmed.2019.00246.
Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.
Chai G, Tan T, Lee Y, Kaw G, Chuah K, Lim Y
Singapore Med J. 2019; 61(6):302-307.
PMID: 31317200
PMC: 7905130.
DOI: 10.11622/smedj.2019069.